• The innovative CAR-T cell therapy developed by Dr. Carl H. June is currently applied in hematologic malignancies, and has opened the door to clinical
• This unit will offer personalized and precision treatments without the need for hospital admissions for patients with prostate and neuroendocrine. • The Group has
Barcelona – HM Nou Delfos: +34 649 758 995
Madrid – HM Madrid: +34 629 823 493
León – HM San Francisco: +34 660 171 363
Salamanca – HM Santísima Trinidad: +34 620 284 142
Galicia – HM Modelo: +34 639 139 298
Andalucía – HM Santa Elena: +34 649 044 240
Barcelona – HM Nou Delfos: +34 649 758 995
Madrid – HM Madrid: +34 629 823 493
Galicia – HM Modelo: +34 639 139 298
Andalucía – HM Santa Elena: +34 649 044 240
